PatternsRadar
Sign in

INNOVACAPInnova Captab Limited

NSE
977.80INR-27.50 (-2.74%)Close · 20 Nov 2026
13 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹5,595 CrMarket cap
33.1P/E (TTM)
46.5%Delivery

Filings & corporate actions

14 results filed
CSV
Next results · Q3 FY27
Expected 23 Jan 2027 – 14 Feb 2027
Estimate: filed 23–45 days after quarter end, last 3 times
Dividend
₹2.00 per share · last 30 Jan 2026
2026
  • 13 NovresultsResults · Q2 FY27 · consolidated and standalone-12.5%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026-1.6%NSE
  • 22 AugresultsResults · Q4 FY26 · consolidated-2.3%NSE
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone-0.7%NSE
  • 8 JulshareholdingShareholding · 30 Jun 2026+1.5%NSE
  • 7 MayresultsResults · Q4 FY26 · consolidated and standalone+1.4%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026-0.3%NSE
  • 30 JandividendDividend · ₹2.00 per share+2.6%
  • 23 JanresultsResults · Q3 FY26 · consolidated and standalone+3.4%NSE
  • 7 JanshareholdingShareholding · 31 Dec 2025+0.1%NSE

Reaction to results · all yearsrose on day 0 in 6 of 13 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2713 Nov 2026-12.5%——8.3×
Q1 FY2711 Aug 2026-0.7%+2.0%+16.7%14.4×
Q4 FY267 May 2026+1.4%-0.6%+0.7%1.2×
Q3 FY2623 Jan 2026+3.4%+1.9%+0.8%0.8×
Q2 FY267 Nov 2025-3.5%-4.6%-12.9%1.6×
Q1 FY267 Aug 2025+0.8%-0.4%-5.1%2.1×
Q4 FY2520 May 2025-1.4%-6.5%-5.0%1.3×
Q3 FY255 Feb 2025-5.6%-16.8%-23.9%2.1×
Q2 FY257 Nov 2024+10.4%+12.6%+26.3%13.6×
Q1 FY259 Aug 2024+1.1%+16.8%+26.6%1.1×
Q4 FY2430 May 2024+2.5%+6.0%+6.3%1.2×
Q3 FY2414 Feb 2024-2.4%-4.1%-11.8%0.4×
Q2 FY2419 Jan 2024-2.4%-4.8%-2.3%—
Average-0.7%+0.1%+1.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+30.5%
Profit YoY+43.0%
Interest cost YoY+64.6%
Revenue QoQ+5.4%
Profit QoQ-3.9%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+25.9%—————
Profit+19.5%—————

Key data

Open1,010.00
Day range970.00 – 1,010.00
52-week range622.00 – 1,353.50
From 52w high-27.8%
RSI (14)39.7
ATR (14)56.78
Volume61.6K
Avg volume (20D)87.3K
Rel volume0.71×
Volatility (1Y)39.3%
Turnover₹6.1Cr
Traded value (NSE)₹6.1Cr
VWAP988.93
SMA 50 / 2001,102.43 / 917.02
Price band20%

Delivery percentage

Latest · 20 Nov 202646.5%
20-day avg45.6%
1-year avg49.4%
Percentile (own history)35th
Range8.4–94.2%
Sessions719

Over the last 20 sessions INNOVACAP settled 45.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 49.4%, so recent sessions are running 3.8 points lower than usual. The latest session ranks higher than 35% of the 719 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.20%
Dividend, trailing 12M₹2.00
Paid every year for1 yr
Shareholders36.6K · +1.9% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy1,053 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.74%-16.60%-1.88%-9.81%+12.10%+30.15%

Valuation

Market cap₹5,595 Cr
Market cap (NSE)₹5,595 Cr
Free-float cap₹2,747 Cr
P/E (TTM)33.1
P/E (NSE)34.0
EPS (TTM)29.54
P/B4.8
Net margin (TTM)9.1%
Other income / PBT3.5%
ROE15.4%
Debt / equity0.30
Shares outstanding5.72Cr
Listed29 Dec 2023

Ownership

Promoter50.90%
Promoter Δ QoQ0.00 pp
Public49.10%
FII0.84%
DII19.16%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)450.3447.8470.9496.3
YoY chg+42.3%+42.3%+33.9%+30.5%
Net profit (₹ Cr)42.140.344.142.4
YoY chg+23.2%+36.4%+42.3%+43.0%
Net margin9.4%9.0%9.4%8.5%
EPS7.377.057.717.41

Shareholding over time

By quarter

30 Sept 2026 · promoter 50.90% · public 49.10%
27 Dec 2023: promoter 50.90%31 Dec 2023: promoter 50.90%31 Mar 2024: promoter 50.90%30 Jun 2024: promoter 50.90%30 Sept 2024: promoter 50.90%31 Dec 2024: promoter 50.90%31 Mar 2025: promoter 50.90%30 Jun 2025: promoter 50.90%30 Sept 2025: promoter 50.90%31 Dec 2025: promoter 50.90%31 Mar 2026: promoter 50.90%30 Jun 2026: promoter 50.90%30 Sept 2026: promoter 50.90%
2023-122026-09
  • Promoter
  • Public and others
Promoter
50.90%
Public
49.10%
Promoter change
0.00 pp
Filed
13 Oct 2026
FII
0.84%
DII
19.16%
Promoter pledged
0.00%

Who the public is

Mutual funds
8.66%

-0.52 pp QoQ

Insurance
1.29%

-0.16 pp QoQ

FPI
0.85%

+0.51 pp QoQ

Retail ≤ ₹2L
5.35%

+0.20 pp QoQ

HNI > ₹2L
22.06%

-0.01 pp QoQ

NRI
0.31%

+0.01 pp QoQ

Bodies corporate
1.12%

+0.03 pp QoQ

Shareholders
36,551

+1.9% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
MANOJ LOHARIWALAPromoter · Individual29.07%
VINAY KUMAR LOHARIWALAPromoter · Individual21.81%
GIAN PARKASH AGGARWALIndividual10.19%
ARCHIT AGGARWALIndividual8.74%
CLARUS CAPITAL IAIF3.58%
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK MULTICAP FUNDMutual fund3.47%
CANARA ROBECO MUTUAL FUNDMutual fund3.47%
360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 9AIF2.05%
360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 10AIF1.82%
VEENA DEVIIndividual1.75%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 30 Jan 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2025-261₹2.00₹2.00
Ex-dateRecord dateDeclaredAdjusted
30 Jan 2026—₹2.00₹2.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
−₹16.2Cr
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
9
3 open-market of the newest 9
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
3 Oct 2026Veena DeviRelativeSell1.00L₹10.8Cr1,080.0010.00L → 9.00L1.57%-0.17 pp7(2)told 30 Sept 2026
3 Oct 2026Gian Parkash AggarwalRelativeSell15.50L₹167.4Cr1,080.0461.82L → 46.32L8.10%-2.71 pp7(2)told 30 Sept 2026
3 Oct 2026Archit AggarwalDirectorSell1.50L₹16.2Cr1,080.0050.00L → 48.50L8.48%-0.26 pp7(2)told 30 Sept 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 2 Jan 2024

CSV
12 of 14 deals
By year
DateDealClientQuantityPriceValue
2 Jan 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP3.46L566.00₹19.6Cr
2 Jan 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP3.46L565.55₹19.6Cr
1 Jan 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.78L525.70₹25.1Cr
1 Jan 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.78L525.68₹25.1Cr
29 Dec 2023Buy · bulkMANSI SHARE AND STOCK ADVISORS PVT LTD9.84L534.89₹52.6Cr
29 Dec 2023Buy · bulkCANARA ROBECO MUTUAL FUND9.00L474.41₹42.7Cr
29 Dec 2023Sell · bulkMANSI SHARE AND STOCK ADVISORS PVT LTD7.66L535.24₹41.0Cr
29 Dec 2023Buy · bulkINVESCO MUTUAL FUND6.00L452.10₹27.1Cr
29 Dec 2023Sell · bulkMUSIGMA SECURITIES4.62L508.32₹23.5Cr
29 Dec 2023Buy · bulkMUSIGMA SECURITIES4.62L508.18₹23.5Cr
29 Dec 2023Sell · bulkGOLDMINE STOCKS PRIVATE LIMITED3.60L502.89₹18.1Cr
29 Dec 2023Buy · bulkGOLDMINE STOCKS PRIVATE LIMITED3.58L502.91₹18.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to INNOVACAP.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26ARQ1 FY27Q2 FY27
Revenue from operations302.5262.6294.3318.2316.5314.7351.5380.4450.3447.8470.9496.3
Other income2.35.72.12.24.33.44.54.21.71.62.02.5
Total income304.8268.3296.4320.4320.8318.1356.0384.6451.9449.4472.9498.8
Total expenses269.6228.8257.1273.6275.2278.8313.3345.3396.3398.7413.9442.5
└ Finance costs6.80.80.10.10.22.02.95.54.04.64.44.3
└ Depreciation4.93.44.95.05.19.811.011.311.411.411.711.8
Profit before tax35.239.539.346.845.639.342.739.255.750.759.056.3
Tax expense10.110.89.811.811.49.711.79.613.510.314.913.9
Net profit25.128.729.535.034.229.631.029.742.140.344.142.4
EPS4.395.025.156.125.975.175.425.187.377.057.717.41
Net margin8.31%10.94%10.02%11.00%10.81%9.40%8.82%7.80%9.36%9.01%9.37%8.55%
PBT margin11.64%15.06%13.36%14.71%14.41%12.49%12.14%10.31%12.36%11.32%12.53%11.34%
Tax rate28.62%27.37%25.01%25.22%24.97%24.77%27.33%24.38%24.30%20.38%25.19%24.65%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 13 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets1,173.51,320.91,434.51,580.41,692.11,837.81,994.1
Current assets567.3579.8585.1695.7812.0923.01,109.4
└ Cash & equivalents3.911.73.415.50.53.214.9
└ Other bank balances56.575.014.852.657.90.70.1
└ Current investments0.00.00.00.00.041.382.9
└ Trade receivables301.4288.5329.1331.6394.9437.3490.2
└ Inventories146.4144.0175.2208.0235.9283.3316.9
Total equity388.5830.9895.3959.41,021.11,081.51,167.6
└ Attributable to owners388.5830.9895.3959.41,021.11,081.51,167.6
└ Non-controlling interest—0.00.00.0—0.00.0
└ Share capital48.057.257.257.257.257.257.2
Borrowings516.2245.1258.7338.1336.5343.7355.5
└ Current162.834.648.793.2106.0127.9154.1
└ Non-current353.4210.5210.0244.9230.4215.8201.4
Trade payables190.0179.7205.1201.8259.8300.1336.7
Current liabilities404.4265.5309.7353.0413.4494.6573.2
Total liabilities785.0490.0539.2621.0671.0756.3826.5
Net debt455.7158.4240.5270.0278.0298.5257.6
Debt / equity1.330.290.290.350.330.320.30
Current ratio1.402.181.891.971.961.871.94

Cash flow, year to date

 H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow78.0146.331.663.829.7115.272.6
└ Capex(151.3)(287.4)(119.9)(172.5)(42.3)(68.3)(25.7)
Free cash flow(73.3)(141.0)(88.3)(108.7)(12.5)46.946.9
Investing cash flow(345.9)(499.0)(55.9)(151.6)(35.5)(105.8)(64.4)
Financing cash flow268.3360.816.091.5(9.2)(21.7)3.1
└ Dividends paid0.00.00.00.00.0(11.4)0.0
└ Buybacks0.00.00.00.00.00.00.0
Net change in cash0.48.2(8.4)3.8(15.0)(12.3)11.2

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

INNOVACAP at a glance

  • INNOVACAP closed at ₹977.8 on 20 Nov 2026, -2.74% on the day, +30.1% over one year, 27.8% below its 52-week high of ₹1,353.5.
  • Delivery was 46.5% of traded quantity on 20 Nov 2026, the 35th percentile of its own 719 sessions with a reading (20-session average 45.6%, 1-year average 49.4%).
  • Market capitalisation is ₹5,595 crore at a trailing P/E of 33.1 (trailing EPS ₹29.54).
  • Q2 FY27 results (consolidated, filed 13 Nov 2026): revenue ₹496 crore (+30.5% year on year), net profit ₹42 crore (+43.0%); the price moved -12.5% on the first session after.
  • Promoters held 50.90% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 23 Jan 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0DUT01020
SeriesEQ
Listed29 Dec 2023
IPO price448.00 · band Rs.426 to Rs.448
IPO listing29 Dec 2023
NSE market cap · 17 Nov 2026₹5,938 Cr
Free-float market cap (NSE)₹1,652 Cr
Shares outstanding (NSE)5.72Cr
History from29 Dec 2023
Sessions719
Turnover rank#998

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.